Analysed ICECURE MEDICAL LTD (ICCM:NASDAQ) News Sources
Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ...
21-05-2026
yahoo.com
IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance
02-06-2026
yahoo.com
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance
17-06-2026
yahoo.com
ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally?
17-06-2026
stocktwits.com
IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor
17-06-2026
yahoo.com
IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer
23-06-2026
yahoo.com
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
06-07-2026
yahoo.com
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
14-07-2026
yahoo.com
What is the current price of ICECURE MEDICAL LTD (ICCM:NASDAQ)?
The current price of ICECURE MEDICAL LTD (ICCM:NASDAQ) is $2.79.
ICECURE MEDICAL LTD (ICCM:NASDAQ) absolute price change since previous trading day?
The absolute price change of ICECURE MEDICAL LTD (ICCM:NASDAQ) since the previous trading day is $-0.09.
ICECURE MEDICAL LTD (ICCM:NASDAQ) percentage price change since previous trading day?
The percentage price change of ICECURE MEDICAL LTD (ICCM:NASDAQ) since the previous trading day is -3.125%.
What is the most recent average sentiment score for ICECURE MEDICAL LTD (ICCM:NASDAQ)?
The most recent average sentiment score for ICECURE MEDICAL LTD (ICCM:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for ICECURE MEDICAL LTD (ICCM:NASDAQ)?
The most recent sentiment for ICECURE MEDICAL LTD (ICCM:NASDAQ) is .
SEC-8K** Filing Available For ICECURE MEDICAL LTD (ICCM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.